On ECHEMI
Home > Drugs > Central nervous system infections
Central nervous system infections
Central nervous system infections include meningitis (inflammation of the meninges or lining of the brain), encephalitis (clinical manifestations of the brain caused by bacterial invasion of the central nervous system), encephalitis (clinical manifestations of the brain caused by viral infection of the central nervous system), abscesses, and helminthic infections. The central nervous system is highly resistant to invasion by various pathogens, but once the brain and spinal cord are infected, the consequences are very serious.
  • Site of disease:

    Brain
  • Infectious :

    Not contagious
  • Frequent population:

    child
  • Related symptoms:

    Mental depression Unexplained fever Drowsiness Neck pain
Related Drugs
Netilmicin Sulfate Injection
Indication: 1. This product is suitable for the treatment of severe infections caused by sensitive Gram-negative bacilli, such as neonatal sepsis, septicemia, central nervous system infection (including meningitis), urinary tract and reproductive system infection, respiratory tract infection, gastrointestinal tract infection, peritonitis, biliary tract infection, skin or bone infection, otitis media, sinusitis, soft tissue infection, listeriosis, etc. caused by Pseudomonas aeruginosa, Proteus (indole positive and negative), Escherichia coli, Klebsiella, Enterobacter, Serratia and Citrobacter. 2. This product can also be used in combination with other antibacterial drugs to treat staphylococcal infections, but it is often ineffective against methicillin-resistant staphylococcal infections.
Manufacturer:

Henan Runhong Pharmaceutical Co., Ltd.

Netilmicin Sulfate Injection
Indication: 1This product is suitable for the treatment of severe infections caused by sensitive Gram-negative bacilli. Such as neonatal sepsis, septicemia, central nervous system infection (including meningitis), urinary tract and reproductive system infection, respiratory tract infection, gastrointestinal tract infection, peritonitis, biliary tract infection, skin or bone infection, otitis media, sinusitis, soft tissue infection, listeriosis, etc. caused by Pseudomonas aeruginosa, Proteus (indole positive and negative), Escherichia coli, Klebsiella, Enterobacter, Serratia and Citrobacter. 2This product can also be used in combination with other antibacterial drugs to treat staphylococcal infections, but it is often ineffective against methicillin-resistant staphylococcal infections.
Manufacturer:

Huarun Shuanghe Limin Pharmaceutical (Ji'nan) Co., Ltd.

Netilmicin Sulfate Injection
Indication: 1. This product is suitable for the treatment of severe infections caused by sensitive Gram-negative bacilli, such as neonatal sepsis, septicemia, central nervous system infection (including meningitis), urinary tract and reproductive system infection, respiratory tract infection, gastrointestinal tract infection, peritonitis, biliary tract infection, skin or bone infection, otitis media, sinusitis, soft tissue infection, listeriosis, etc. caused by Pseudomonas aeruginosa, Proteus (indole positive and negative), Escherichia coli, Klebsiella, Enterobacter, Serratia and Citrobacter. 2. This product can also be used in combination with other antibacterial drugs to treat staphylococcal infections, but it is often ineffective against methicillin-resistant staphylococcal infections.
Manufacturer:

Fujian Nanshaolin Pharmaceutical Co., Ltd.

Ceftazidime for injection
Indication: It is used for sepsis, lower respiratory tract infection, abdominal and biliary tract infection, complicated urinary tract infection and severe skin and soft tissue infection caused by sensitive Gram-negative bacilli. It is especially suitable for infections in immunocompromised patients caused by multiple drug-resistant Gram-negative bacilli, hospital-acquired infections, and central nervous system infections caused by Gram-negative bacilli or Pseudomonas aeruginosa.
Manufacturer:

CSPC Zhongnuo PHARMACEUTICAL(Shijiazhuang) Co., Ltd.

Ceftazidime for injection
Indication: It is used for sepsis, lower respiratory tract infection, abdominal and biliary tract infection, complicated urinary tract infection and severe skin and soft tissue infection caused by sensitive Gram-negative bacilli. It is especially suitable for infections in immunocompromised patients caused by multiple drug-resistant Gram-negative bacilli, hospital-acquired infections, and central nervous system infections caused by Gram-negative bacilli or Pseudomonas aeruginosa.
Ceftazidime for injection
Indication: It is used for sepsis, lower respiratory tract infection, abdominal and biliary tract infection, complicated urinary tract infection and severe skin and soft tissue infection caused by sensitive Gram-negative bacilli. It is especially suitable for infections in immunocompromised patients caused by multiple drug-resistant Gram-negative bacilli, hospital-acquired infections, and central nervous system infections caused by Gram-negative bacilli or Pseudomonas aeruginosa.
Manufacturer:

Shandong Runze Pharmaceuticals Co., Ltd.

Ceftazidime for injection
Indication: It is used for sepsis, lower respiratory tract infection, abdominal and biliary tract infection, complicated urinary tract infection and severe skin and soft tissue infection caused by sensitive Gram-negative bacilli. It is especially suitable for infections in immunocompromised patients caused by multiple drug-resistant Gram-negative bacilli, hospital-acquired infections, and central nervous system infections caused by Gram-negative bacilli or Pseudomonas aeruginosa.
Manufacturer:

Livzon (GROUP) Pharmaceutical FACTORY

Tobramycin Sulfate Injection
Indication: This product is suitable for neonatal sepsis, septicemia, central nervous system infection (including meningitis), urogenital system infection, lung infection, biliary tract infection, abdominal infection and peritonitis, bone infection, burns, skin and soft tissue infection, acute and chronic otitis media, sinusitis, etc. caused by Pseudomonas aeruginosa, Proteus, Escherichia coli, Klebsiella, Enterobacter, Serratia, or combined with other antibacterial drugs for staphylococcal infection (methicillin-resistant strains are ineffective). This product can be administered by intrathecal injection when used for Pseudomonas aeruginosa meningitis or ventriculitis; it can be inhaled by aerosol as an auxiliary treatment when used for bronchial and lung infections. This product is ineffective for most group D streptococcal infections.
Manufacturer:

Livzon (GROUP) Pharmaceutical FACTORY

Tobramycin Sulfate Injection
Indication: This product is suitable for neonatal sepsis, septicemia, central nervous system infection (including meningitis), urogenital system infection, lung infection, biliary tract infection, abdominal infection and peritonitis, bone infection, burns, skin and soft tissue infection, acute and chronic otitis media, sinusitis, etc. caused by Pseudomonas aeruginosa, Proteus, Escherichia coli, Klebsiella, Enterobacter, Serratia, or combined with other antibacterial drugs for staphylococcal infection (methicillin-resistant strains are ineffective). This product can be administered by intrathecal injection when used for Pseudomonas aeruginosa meningitis or ventriculitis; it can be inhaled by aerosol as an auxiliary treatment when used for bronchial and lung infections. This product is ineffective for most group D streptococcal infections.
Manufacturer:

Changzhou Lanling Pharmaceutical Co., Ltd.

Tobramycin Sulfate Injection
Indication: This product is suitable for neonatal sepsis, septicemia, central nervous system infection (including meningitis), urogenital system infection, lung infection, biliary tract infection, abdominal infection and peritonitis, bone infection, burns, skin and soft tissue infection, acute and chronic otitis media, sinusitis, etc. caused by Pseudomonas aeruginosa, Proteus, Escherichia coli, Klebsiella, Enterobacter, and Serratia, or combined with other antibacterial drugs for staphylococcal infection (methicillin-resistant strains are ineffective). This product can be administered by intrathecal injection when used for Pseudomonas aeruginosa meningitis or ventriculitis; it can be inhaled by aerosol as an auxiliary treatment when used for bronchial and lung infections. This product is ineffective for most group D streptococcal infections.
Manufacturer:

Dali Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.